Erosive Esophagitis: Clinical Trials

4 trials for Erosive Esophagitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1

Follow Erosive Esophagitis: new trials by email Literature Review of Erosive Esophagitis trials Research Report on Erosive Esophagitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
Dexlansoprazole - Erosive Esophagitis
Phase 2TerminatedTakeda242023-05-232026-05-06
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
X842, X842 Dummy, Lansoprazole - Erosive Esophagitis
Phase 2CompletedCinclus Pharma Holding AB2482021-08-112026-07-01
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
CJ-12420, Esomeprazole - Erosive Esophagitis, GERD
Phase 2CompletedHK inno.N Corporation2062013-05-012014-08-08
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents
Dexlansoprazole, Placebo - Gastroesophageal Reflux Disease, Erosive Esophagitis
Phase 2CompletedTakeda632012-07-012015-05-27

Narrower conditions

Gastroesophageal Reflux (2)

Broader conditions

Deglutition Disorders (2)  ·  Digestive System Diseases (2)  ·  Esophageal Diseases (2)  ·  Esophageal Motility Disorders (2)  ·  Gastrointestinal Diseases (2)

Interventions

Dexlansoprazole (2)  ·  Esomeprazole (1)  ·  Lansoprazole (1)

Sponsors

Takeda (2)  ·  Cinclus Pharma Holding AB (1)  ·  HK inno.N Corporation (1)

Countries

Poland (3)  ·  United States (3)  ·  Hungary (2)  ·  Mexico (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Georgia (1)  ·  Italy (1)  ·  Portugal (1)  ·  Serbia (1)  ·  South Korea (1)

Top investigators

Hyun-Chae Jung, MD, PhD (1)

Results publications

PMID 40183130, PMID 40470733